Barclays raised the firm’s price target on Intuitive Surgical to $490 from $430 and keeps an Overweight rating on the shares. The firm made changes to its EBITDA projections and increased the price target ahead of the earnings report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $515 from $450 at Truist
- ISRG Earnings this Week: How Will it Perform?
- Intuitive Surgical price target raised to $460 from $375 at Morgan Stanley
- Intuitive Surgical price target raised to $459 from $451 at BTIG
- Options Volatility and Implied Earnings Moves This Week, July 15 – July 19, 2024